Navigation Links
Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants
Date:7/25/2008

New York Resident Expected To Regain Hearing in Both Ears for the First

Time in Over 40 Years

DENVER, July 25 /PRNewswire/ -- Cochlear, the world's leader in advanced hearing technologies, today announced a landmark milestone when Dr. Thomas Roland, Jr., MD of NYU Langone Medical Center performs the 120,000th cochlear implant device procedure. Today, 72-year-old New York resident, Susan Grossman, will undergo surgery to receive bilateral (a device in each ear) Nucleus(R) Freedom cochlear implants.

Cochlear implants have the ability to restore hearing for individuals who are severely hard of hearing and for whom hearing aids don't help much, and those who are profoundly deaf. A cochlear implant is a device, which bypasses damaged hair cells in the inner ear, or cochlea, that stimulates the hearing nerve directly, effectively restoring hearing to individuals. These devices are a proven medical option for adults and children as young as twelve months old.

"Cochlear implants are the most effective treatment for people with severe to profound hearing loss and are becoming the standard of care globally," said Dr. Roland. "In fact, it is becoming common practice for people to now receive a device in both ears, as the clinical evidence clearly demonstrates the benefit. At NYU, we do more than five implants per week and this continues to grow each year." The NYU team of audiologists currently manage about 1800 recipients.

"Cochlear implants are the only medical device designed to restore one of the five human senses. With this technology, people with severe to profound hearing loss no longer have to live in a world of silence," said Chris Smith, President Cochlear Americas. "We celebrate this milestone with the dedicated clinicians who have helped us to positively impact the lives of so many people, like Susan Grossman, with the gift of hearing. An estimated 1 million people in the United States could benefit from
'/>"/>

SOURCE Cochlear
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Beckman Coulter Announces Second Quarter 2008 Results
2. Rochester Medical Announces Third Quarter 2008 Earnings Conference Call July 31, 2008
3. Instrumentation Laboratory Announces Contract for Multi-Parameter Testing Products with Broadlane
4. Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research
5. Monsanto Announces Key Regulatory Approvals for Roundup Ready 2 Yield(TM) Soybeans; Product Remains on Track for 2009 Launch
6. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants
7. Neurocrine Biosciences Announces Conference Call and Webcast To Present Second Quarter 2008 Financial Results
8. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation from Board of Directors of Jitendra Doshi and Appointment of GP Singh Sachdeva
9. Chromos Announces Full Revocation of Cease Trade Orders
10. Pioneer(R) Surgical Technology, Inc. Announces the Market Launch of the SlimFuse(TM) Anterior Cervical Plate System
11. NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... , - Results From ... Rheumatoid Arthritis in Seven Major Industrialized Countries , , ... arthritis say their disease, impacts ... Women living with rheumatoid arthritis find shopping for gifts, ... wrapping presents most, difficult to ...
(Date:12/11/2009)... Boston College researchers have observed the "hot electron" ... and successfully harvested the elusive charges using ultra-thin solar ... efficiency, the authors report in the current online edition ... is captured in solar cells, it generates free electrons ... to snare these charges, the electrons must reach the ...
(Date:12/11/2009)... Inc. (TSX:ONC, NASDAQ: ONCY ) ("Oncolytics" or the ... Warrander to the role of Senior Vice President, ... will be responsible for the execution of the ... Thompson, President and CEO of Oncolytics. "Having reached ... 3 trial examining REOLYSIN in combination with paclitaxel ...
(Date:12/10/2009)... Eye Institute (NEI), a division of the National Institutes of ... to help fund its development of a non-invasive, passive diffusion-based ... ... Salt Lake City, UT (PRWEB) December 10, ... the National Institutes of Health (NIH), awarded a $2.18 million ...
Breaking Biology Technology:Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Elusive 'hot' electrons captured in ultra-thin solar cells 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3
... announced that it is producing the Wisconsin Intellectual Capital ... 25, from 8:30 a.m. to 3:45 p.m. at the ... ,Wisconsins medical device and technology cluster is a key ... Department of Commerce (Commerce) Secretary Cory L. Nettles. This ...
... British education officals visited Madison to determine whether ... time when many Wisconsin leaders are studying how ... it is ironic that across the Atlantic, the ... have turned to Wisconsin to export an idea ...
... editorial titled, "End tax moratorium on Internet services" ... (08/07/03). Wisconsin is only one of ten states that ... growing industry. The notion of putting unnecessary tax burden ... need to encourage the growth of the technology and ...
Other Biology Technology:Medical Technologies and Devices Symposium 2Is Wisconsin a Technology Leader or Laggard? 2
(Date:12/11/2009)... Malus orientalis species of wild apples that could be ... Middle East and Central Asia. A new study comparing ... varieties from Georgia and Armenia with previously collected varieties ... and establishes a core collection that will make ... research communities. , To identify and record the genetic ...
(Date:12/11/2009)... how bacteria under stress collectively weigh and initiate different ... how humans make strategic decisions that affect their health, ... Their study, published this week in the early online ... Academy of Sciences , was accomplished when the scientists ... the complex interplay of genes and proteins that colonies ...
(Date:12/11/2009)... has granted an 18-month, exclusive option to startup ... analogs. The company must reach certain milestones in ... exclusive license on therapies designed to help patients ... treatments that it hopes will become an important ... market. Insulin is a therapeutic protein used to ...
Breaking Biology News(10 mins):Understanding apples' ancestors 2Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5Case Western Reserve University grants option to startup Thermalin Diabetes Inc. 2Delcath Systems Inc Completes Phase III Study Enrollment 5635 1Delcath Systems Inc Completes Phase III Study Enrollment 5635 2Delcath Systems Inc Completes Phase III Study Enrollment 5635 3NASCSA Receives 24200 000 Grant From Purdue Pharma L P to Support State Prescription Drug Monitoring Programs 5633 1NASCSA Receives 24200 000 Grant From Purdue Pharma L P to Support State Prescription Drug Monitoring Programs 5633 2Long Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax 28R 29 Brain 5631 1Long Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax 28R 29 Brain 5631 2Long Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax 28R 29 Brain 5631 3Long Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax 28R 29 Brain 5631 4Long Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax 28R 29 Brain 5631 5
... DNA sequencing is the next frontier in biological research.As ... is increasingly available to small laboratories. Thus, sequencing ... ever before. , However, the computing capacity needed to ... catching up to do. Large networks of interconnected ...
... GENEVA/LAUSANNE Researchers from the Universities of Geneva and ... have been part of a major international project to ... named L1 Dominette. Sequencing the bovine genome is now ... food production, taking into account the needs of an ...
... has launched the Web site www.SpringerExemplar.com , a ... for authors, editors and the scientific community in general. ... quickly see how a particular term or phrase is ... and open to anyone with an internet connection. , ...
Other Biology News:A genomic CluE for cloud computing 2A genomic CluE for cloud computing 3Sequencing the cow's genetic code -- a new agricultural era dawns 2
Request Info...
Tight junctions are complexes of proteins that create intercellular boundaries between the plasma membrane domains of epithelial and endothelial cells. Antigen: Synthetic peptide corresponding to...
Myeloid Marker (BM-1)...
Form: Concentrated Applications: ELISA...
Biology Products: